Page last updated: 2024-08-24

aripiprazole and pramipexole

aripiprazole has been researched along with pramipexole in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Blackwell, W; Brockel, B; Campbell, JB; Rosamond, J; Steelman, G; Urbanek, RA; Wesolowski, SS; Widzowski, DV; Wu, Y; Xiong, H; Zhang, M1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dengler, D; Gmeiner, P; Hübner, H; Männel, B; Möller, D; Shonberg, J1
Greenway, LL; Kuppuswamy, PS; Lauterbach, EC1
Glenmullen, J; Mattison, DR; Moore, TJ1
Carleton, BC; Etminan, M; Guo, M; Procyshyn, RM; Samii, A; Sodhi, M1
Håkansson, A; Wolfschlag, M1

Reviews

1 review(s) available for aripiprazole and pramipexole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for aripiprazole and pramipexole

ArticleYear
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonists.
    Bioorganic & medicinal chemistry letters, 2013, Jan-15, Volume: 23, Issue:2

    Topics: Animals; Antipsychotic Agents; Benzazepines; Biological Assay; Disease Models, Animal; Dopamine Agonists; Drug Partial Agonism; Humans; Inhibitory Concentration 50; Molecular Structure; Protein Binding; Rats; Receptors, Dopamine D2; Structure-Activity Relationship

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D
    Journal of medicinal chemistry, 2017, 06-08, Volume: 60, Issue:11

    Topics: Animals; beta-Arrestins; CHO Cells; Cricetulus; Dopamine Agonists; Humans; Piperazines; Receptors, Dopamine D2

2017
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
    Neurocase, 2010, Volume: 16, Issue:5

    Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors

2010
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    JAMA internal medicine, 2014, Volume: 174, Issue:12

    Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration

2014
Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
    Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Canada; Case-Control Studies; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole

2017
Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
    PloS one, 2021, Volume: 16, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aripiprazole; Behavior, Addictive; Cross-Sectional Studies; Dopamine; Dopamine Agonists; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole; Registries; Reward; Risk Factors; Sweden; Young Adult

2021
chemdatabank.com